{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:37:34Z","timestamp":1762508254999},"reference-count":13,"publisher":"American Medical Association (AMA)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2020,10,6]]},"DOI":"10.1001\/jama.2020.18860","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T16:19:25Z","timestamp":1599754765000},"page":"1296","source":"Crossref","is-referenced-by-count":22,"title":["Reassuring the Public and Clinical Community About the Scientific Review and Approval of a COVID-19 Vaccine"],"prefix":"10.1001","volume":"324","author":[{"given":"Howard","family":"Bauchner","sequence":"first","affiliation":[{"name":"Editor in Chief, JAMA and the JAMA Network"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preeti N.","family":"Malani","sequence":"additional","affiliation":[{"name":"University of Michigan Health System, Division of Infectious Diseases, Ann Arbor"},{"name":"Associate Editor, JAMA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Sharfstein","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"key":"jed200089r1","article-title":"Unwavering regulatory safeguards for COVID-19 vaccines.","author":"Shah","journal-title":"JAMA"},{"key":"jed200089r2","article-title":"Emergency use authorizations during the COVID-19 pandemic: lessons from hydroxychloroquine for vaccine authorization and approval.","author":"Thomson","journal-title":"JAMA"},{"issue":"6","key":"jed200089r13","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1001\/jama.2020.13167","article-title":"The Advisory Committee on Immunization Practices and its role in the pandemic vaccine response.","volume":"324","author":"Lee","year":"2020","journal-title":"JAMA"},{"key":"jed200089r3","unstructured":"Kaplan S, Wu KJ, Thomas K. C.D.C. tells states how to prepare for Covid-19 vaccine by early November. New York Times. Published September 2, 2020. Accessed September 7, 2020. https:\/\/www.nytimes.com\/2020\/09\/02\/health\/covid-19-vaccine-cdc-plans.html"},{"key":"jed200089r4","unstructured":"Dall C. CEO says Pfizer won't cut corners in COVID vaccine race. Center for Infectious Disease Research and Policy. September 3, 2020. Accessed September 7, 2020. https:\/\/www.cidrap.umn.edu\/news-perspective\/2020\/09\/ceo-says-pfizer-wont-cut-corners-covid-vaccine-race"},{"key":"jed200089r5","unstructured":"Loftus P, Hopkins JS. Covid-19 vaccine developers prepare joint pledge on safety, standards. The Wall Street Journal. September 4, 2020. Accessed September 7, 2020. https:\/\/www.wsj.com\/articles\/covid-19-vaccine-developers-prepare-joint-pledge-on-safety-standards-11599257729"},{"key":"jed200089r6","unstructured":"Operation Warp Speed top adviser on the status of a coronavirus vaccine. Transcript. All Things Considered. NPR. September 3, 2020. Accessed September 8, 2020. https:\/\/www.npr.org\/2020\/09\/03\/909312697\/operation-warp-speed-top-adviser-on-the-status-of-a-coronavirus-vaccine"},{"key":"jed200089r7","unstructured":"Biopharma leaders unite to stand with science. News release. September 8, 2020. Accessed September 8, 2020. https:\/\/www.businesswire.com\/news\/home\/20200908005282\/en\/Biopharma-Leaders-Unite-Stand-Science"},{"key":"jed200089r8","unstructured":"Rowland C. Vaccine CEOs issue safety pledge amid Trump\u2019s quest for pre-election approval. September 8, 2020. Accessed September 8, 2020. https:\/\/www.washingtonpost.com\/business\/2020\/09\/08\/vaccine-safety-pledge-ceos\/"},{"key":"jed200089r9","unstructured":"Crist C. WebMD poll: more acceptance of COVID vaccine. September 2, 2020. Accessed September 8, 2020. https:\/\/www.webmd.com\/lung\/news\/20200902\/webmd-poll-more-acceptance-of-covid-vaccine"},{"key":"jed200089r10","unstructured":"McGinley L, Johnson CY. Debate rages over whether FDA should use emergency powers to clear a coronavirus vaccine early. September 2, 2020. Accessed September 8, 2020. https:\/\/www.washingtonpost.com\/health\/2020\/09\/02\/fda-coronavirus-vaccine-emergency-authority\/"},{"key":"jed200089r11","unstructured":"Vaccines and Related Biological Products Advisory Committee. FDA. Updated April 26, 2019. Accessed September 7, 2020. https:\/\/www.fda.gov\/advisory-committees\/blood-vaccines-and-other-biologics\/vaccines-and-related-biological-products-advisory-committee"},{"key":"jed200089r12","unstructured":"Coronavirus (COVID-19) Update: FDA announces Advisory Committee meeting to discuss COVID-19 vaccines. News release. FDA. August 28, 2020. Accessed September 8, 2020. https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-announces-advisory-committee-meeting-discuss-covid-19-vaccines"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2770681\/jama_bauchner_2020_ed_200089_1601660236.89177.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T15:01:40Z","timestamp":1601996500000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2770681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":13,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,10,6]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2020.18860","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,6]]}}}